 |
Hosted by Aramco, the Saudi Arabian Ministry of Health and Welfare and hosted by the Royal Family Office, the forum will be held around the end of April, after Ramadan, at Mansar Riyadh, A Radisson Collection Hotel in Riyadh, Saudi Arabia's capital.
NKCL Bio Group is a company that leads the next-generation anti-cancer market through immune anti-cancer drugs that use NK cells and is a company that leads anti-aging products and services based on that technology. It is a company that leads the 'personalized immune care' market by expanding its business areas in a multifaceted manner through expansion, the establishment of a GMP automatic culture center, and commercialization of microbiome food.
Local participants in this forum will include Saudi royals, high-ranking cancer-related government officials, and officials from government hospitals.
In particular, medical surgical equipment company introduction and hospital introduction speech, Saudi hospital establishment and medical equipment export individual consultation-investment matching, Korean cancer-related hospital and university hospital Saudi branch establishment speech, anti-aging hospital establishment and royal patient attraction, etc. proceeded.
According to officials, currently, 20 companies have expressed their intention to participate in the forum, and the following 30 companies are currently recruiting. Locally preferred medical fields are plastic surgery, male plastic surgery, reconstructive plastic surgery (wound reconstruction, nose, ear, etc.), obesity hospitals, NK cell companies and stem cell companies, cancer-related companies, anti-aging companies, cosmetics, medical blockchain startups, etc.
2023/01/14 09:20 KST
